P53 gene mutations are associated with shortened survival, in patients with advanced non-small cell lung cancer.

被引：0
作者：
Murakami, I
Hiyama, K
Yamakido, M
Kasagi, F
Yokosaki, Y
机构：
[1] Natl Hiroshima Hosp, Dept Internal Med, Dept Lab Med, Hiroshima, Japan
[2] Hiroshima Univ, Dept Internal Med 2, Sch Med, Hiroshima 730, Japan
[3] Radiat Effects Res Fdn, Dept Stat, Hiroshima, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A714 / A714
页数：1
相关论文
共 50 条
  • [41] Improvement in Survival in Patients With Advanced Non-small Cell Lung Cancer
    Yoshida, Keishi
    Watanabe, Kaoru
    Nishimura, Taku
    Ikushima, Hiroaki
    Ohara, Sayaka
    Takeshima, Hideyuki
    Sakatani, Toshio
    Usui, Kazuhiro
    ANTICANCER RESEARCH, 2025, 45 (01) : 295 - 305
  • [42] Frequency of EGFR mutations in peruvian patients with non-small cell lung cancer.
    Gomez de la Torre, Juan C.
    Storace, Angelo
    Piscocha, Christian
    Landa, Jose
    Roe, Carlos
    Roe, Eduardo
    Barletta, Claudia
    Mas, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer
    U. Vogt
    A. Zaczek
    F. Klinke
    A. Granetzny
    K. Bielawski
    B. Falkiewicz
    Journal of Cancer Research and Clinical Oncology, 2002, 128 : 141 - 147
  • [44] A study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer
    Tammemagi, MC
    McLaughlin, JR
    Mullen, JBM
    Bull, SB
    Johnston, MR
    Tsao, MS
    Casson, AG
    ANNALS OF EPIDEMIOLOGY, 2000, 10 (03) : 176 - 185
  • [45] p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer
    Vogt, U
    Zaczek, A
    Klinke, F
    Granetzny, A
    Bielawski, K
    Falkiewicz, B
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (03) : 141 - 147
  • [46] Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer
    Maniwa, Y
    Yoshimura, M
    Obayashi, C
    Inaba, M
    Kiyooka, K
    Kanki, M
    Okita, Y
    CHEST, 2001, 120 (02) : 589 - 594
  • [47] p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland
    Niklinska, W
    Burzykowski, T
    Chyczewski, L
    Rusin, MR
    Furman, M
    Laudanski, J
    Chyczewska, E
    Sulik, M
    Niklinski, J
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2000, 9 (02) : 81 - 87
  • [48] Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer
    Huang, CL
    Taki, T
    Adachi, M
    Konishi, T
    Higashiyama, M
    Kinoshita, M
    Hadama, T
    Miyake, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (03) : 553 - 563
  • [49] Complete p53 mutation analysis, allelic loss and microsatellite instability in non-small cell lung cancer.
    Saunders, E
    Shipman, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A320 - A320
  • [50] High frequency of p53 mutations in non-small cell lung cancer detected with yeast functional assay
    Monzo, M
    Gumerlock, P
    Shi, XB
    Martin, G
    Gomez-Codina, J
    Pifarre, A
    Astudillo, J
    Gandara, D
    Rosell, R
    ANNALS OF ONCOLOGY, 1998, 9 : 88 - 88
12345